CN102166303B - Chinese medicinal composition for treating chronic atrophic gastritis - Google Patents
Chinese medicinal composition for treating chronic atrophic gastritis Download PDFInfo
- Publication number
- CN102166303B CN102166303B CN2011100859401A CN201110085940A CN102166303B CN 102166303 B CN102166303 B CN 102166303B CN 2011100859401 A CN2011100859401 A CN 2011100859401A CN 201110085940 A CN201110085940 A CN 201110085940A CN 102166303 B CN102166303 B CN 102166303B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- parched
- atrophic gastritis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating chronic atrophic gastritis, which belongs to the composition of the traditional Chinese medicine and is prepared form offcinal Magnolia bark, poria, Chinese Angelica, red-rooted salvia root, tree peony bark, red peony root, fried yam, fried bighead atractylodes rhizome, common bletilla pseudobulb, bergamot and fried liquorice according to a certain weight ratio. The Chinese medicinal composition has functions of tonifying the spleen and the stomach and promoting the digestion and the circulation of Qi, and can effectively treat chronic atrophic gastritis.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, especially a kind of Chinese medicine composition of treating chronic atrophic gastritis.
Background technology
Chronic atrophic gastritis is also claimed atrophic gastritis.Be meant the intrinsic body of gland atrophy of mucosa that causes after gastric mucosa surface suffers damage repeatedly, even disappear the common pathological change that thickens of muscular layer of mucosa.Because body of gland atrophy or disappearance, gastric mucosa has attenuation in various degree, and often with intestinal epithelial metaplasia, inflammatory reaction and atypical hyperplasia.This disease is one of digestive system common disease, and in the general crowd of China, the sickness rate of chronic gastritis is very high, and wherein atrophic gastritis accounts for 13.8% of the number examined.The many mistake by chronic superficial gastritis of chronic atrophic gastritis controlled or wrong treatment is transformed, and the minority atrophic gastritis can develop into gastric cancer.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition, it is fast that this Chinese medicine composition has curative effect for the treatment chronic atrophic gastritis, characteristics such as short treating period.
The present invention selects Cortex Magnoliae Officinalis, Poria, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Cortex Moutan, Radix Paeoniae Rubra, Rhizoma dioscoreae (parched), Rhizoma Atractylodis Macrocephalae (parched), Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Citri Sarcodactylis and Radix Glycyrrhizae Preparata to make up; Make each efficacy of drugs produce synergism these drug regimens; Make it to have the spleen reinforcing stomach function regulating, the effect of removing food stagnancy circulation of qi promoting, thereby can effectively treat chronic atrophic gastritis.
Wherein: Cortex Magnoliae Officinalis: be bark, root bark and the branch skin of Magnoliacea plant Cortex Magnoliae Officinalis and Mount Lushan Cortex Magnoliae Officinalis.Nature and flavor are bitter, suffering, temperature.Return spleen, stomach, large intestine channel.Have circulation of qi promoting removing food stagnancy, dampness except that full effect, cure mainly stagnation of QI due to dyspepsia, abdominal distention constipation, retention of dampness in middle-JIAO, the vomiting and diarrhoea of gastral cavity painful abdominal mass.
Poria: be the dry sclerotia of Polyporaceae fungus Poria Poria cocos (Schw.) Wolf.Nature and flavor are sweet, and are light, flat.Go into the heart, lung, spleen channel.Effect with eliminating dampness and diuresis, invigorating the spleen and regulating the stomach.
Radix Angelicae Sinensis: be the root of umbelliferae angelica Angelica sinensis (0liv.) Diels.The nature and flavor temperature, sweet, hot.Return liver, the heart, spleen channel.Having enriches blood invigorates blood circulation, the effect of loosening bowel to relieve constipation.
Radix Salviae Miltiorrhizae: be the dry root and rhizome of dicotyledon Labiatae Labiatae salvia Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..Nature and flavor are bitter, are slightly cold.GUIXIN, Liver Channel.Has promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, the effect of removing heat from blood eliminating carbuncle.
Cortex Moutan: be the dry root bark of ranunculaceae peony.Nature and flavor are cold, hardship.GUIXIN, liver, kidney, lung meridian.Effect with clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.
Radix Paeoniae Rubra: be the dry root of ranunculaceae plant Radix Paeoniae Paeonia lactiflora Pall. or river Radix Paeoniae Rubra Paeonia veitchii Lynch.Nature and flavor are bitter, are slightly cold.Return Liver Channel.Function with clearing away heat and cooling blood, eliminating stasis to stop pain.
Rhizoma dioscoreae (parched): be the dry rhizome of Dioscoreaceae plant Rhizoma Dioscoreae.Nature and flavor are sweet, and are flat.Go into lung, spleen, kidney channel.Have invigorating spleen and reinforcing stomach, digestant effect.
Rhizoma Atractylodis Macrocephalae (parched): be the dry rhizome of feverfew Rhizoma Atractylodis Macrocephalae Atractylodes macrocephala Koidz..Nature and flavor are bitter, sweet, temperature.Return spleen, stomach warp.Has invigorating the spleen and benefiting QI, the effect of dampness diuretic.Be used for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels.
Fructus Citri Sarcodactylis: be the fruit of rutaceae Fructus Citri Sarcodactylis Citrus medica L.var.sarcodactylis Swingle.Nature and flavor are hot, bitter, sour, temperature.Return liver, spleen, lung meridian.Has liver-smoothing, qi-regulating, the effect of stomach function regulating analgesic.Be used for stagnation of liver-QI and stomach-QI, distending pain in the chest and hypochondrium, gastral cavilty feeling of fullness, lack of appetite vomiting.
Radix Glycyrrhizae Preparata: for the honey of Radix Glycyrrhizae is smoked processed goods.Nature and flavor are sweet, and are flat.GUIXIN, lung, spleen, stomach warp.Has the spleen reinforcing stomach function regulating, Yiqi and vein recovery.Be used for weakness of the spleen and stomach, fatigue and weakness.
Medicine material consumption of the present invention is groped to sum up to draw through the inventor in a large number, and each raw material consumption is for all to have curative effect preferably in the following weight parts scope: Cortex Magnoliae Officinalis 10-15 part, Poria 25-35 part, Radix Angelicae Sinensis 20-28 part, Radix Salviae Miltiorrhizae 25-35 part, Cortex Moutan 10-15 part, Radix Paeoniae Rubra 10-15 part, Rhizoma dioscoreae (parched) 12-18 part, Rhizoma Atractylodis Macrocephalae (parched) 20-28 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 12-18 part, Fructus Citri Sarcodactylis 10-15 part, Radix Glycyrrhizae Preparata 12-18 part.
Wherein be preferably: 12 parts of Cortex Magnoliae Officinalis, 30 parts in Poria, 24 parts of Radix Angelicae Sinensis, 30 parts of Radix Salviae Miltiorrhizaes, 12 parts of Cortex Moutans, 12 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma dioscoreae (parched)s, 24 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 parts of Fructus Citri Sarcodactylis, 15 parts of Radix Glycyrrhizae Preparatas.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, like pill, powder, tablet, oral liquid etc.For example can these crude drug pulverize mix homogeneously be processed powder takes after mixing it with water; Can use decocting,, add antiseptic and process oral liquid through filtering filtrating; Also can directly take decoction in case of necessity.
Medicine of the present invention has effects such as spleen reinforcing stomach function regulating, removing food stagnancy circulation of qi promoting, and short treating period is evident in efficacy, without any side effects, according to clinical 200 routine patients are observed statistics, takes medicine total effective rate course of treatment total effective rate 85%, two course of treatment 91% of the present invention.
The specific embodiment
Embodiment one, 10 parts of Cortex Magnoliae Officinalis, 25 parts in Poria, 20 parts of Radix Angelicae Sinensis, 25 parts of Radix Salviae Miltiorrhizaes, 10 parts of Cortex Moutans, 10 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma dioscoreae (parched)s, 20 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 12 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 10 parts of Fructus Citri Sarcodactylis, 12 parts of Radix Glycyrrhizae Preparatas.
Embodiment two, 12 parts of Cortex Magnoliae Officinalis, 30 parts in Poria, 24 parts of Radix Angelicae Sinensis, 30 parts of Radix Salviae Miltiorrhizaes, 12 parts of Cortex Moutans, 12 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma dioscoreae (parched)s, 24 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 parts of Fructus Citri Sarcodactylis, 15 parts of Radix Glycyrrhizae Preparatas.
Embodiment three, 15 parts of Cortex Magnoliae Officinalis, 35 parts in Poria, 28 parts of Radix Angelicae Sinensis, 35 parts of Radix Salviae Miltiorrhizaes, 15 parts of Cortex Moutans, 15 parts of Radix Paeoniae Rubra, 18 parts of Rhizoma dioscoreae (parched)s, 28 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 18 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 15 parts of Fructus Citri Sarcodactylis, process 18 parts of sweet lists.
Be the clinical statistics data that the patient uses medicine of the present invention below:
One, physical data
Accept out-patient's totally 200 examples for medical treatment, male's 123 examples wherein, women's 77 examples, men and women's ratio 1.6: 1,52 years old mean age.
Two, diagnostic criteria
Feed back epigastric discomfort or pain show as irregular persistence epigastrium pain, or inappetence is arranged, feel sick, the abdominal distention belch, tired, become thin, suffer from diarrhoea, the how light or extra dry red wine no fur of body of the tongue.
Three, Therapeutic Method
According to drug weight proportioning of the present invention, weighting raw materials (daily dose), decocting, filter and remove residue is taken at twice, and 15 is a course of treatment.
Four, efficacy assessment standard
Recovery from illness: clinical symptoms, sign disappear or basic the disappearance.
Produce effects: clinical symptoms, sign are obviously improved.
Invalid: sings and symptoms does not have significant change.
Five, therapeutic outcome statistics
Wherein: total effective rate=cure rate+obvious effective rate
Claims (2)
1. a Chinese medicine composition of treating chronic atrophic gastritis is characterized in that it is to be processed by the raw material of following weight portion: Cortex Magnoliae Officinalis 10-15 part, Poria 25-35 part, Radix Angelicae Sinensis 20-28 part, Radix Salviae Miltiorrhizae 25-35 part, Cortex Moutan 10-15 part, Radix Paeoniae Rubra 10-15 part, Rhizoma dioscoreae (parched) 12-18 part, Rhizoma Atractylodis Macrocephalae (parched) 20-28 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 12-18 part, Fructus Citri Sarcodactylis 10-15 part, Radix Glycyrrhizae Preparata 12-18 part.
2. Chinese medicine composition according to claim 1 is characterized in that it is to be processed by the raw material of following weight portion: 12 parts of Cortex Magnoliae Officinalis, 30 parts in Poria, 24 parts of Radix Angelicae Sinensis, 30 parts of Radix Salviae Miltiorrhizaes, 12 parts of Cortex Moutans, 12 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma dioscoreae (parched)s, 24 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 12 parts of Fructus Citri Sarcodactylis, 15 parts of Radix Glycyrrhizae Preparatas.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100859401A CN102166303B (en) | 2011-03-27 | 2011-03-27 | Chinese medicinal composition for treating chronic atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100859401A CN102166303B (en) | 2011-03-27 | 2011-03-27 | Chinese medicinal composition for treating chronic atrophic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166303A CN102166303A (en) | 2011-08-31 |
| CN102166303B true CN102166303B (en) | 2012-04-18 |
Family
ID=44487746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100859401A Expired - Fee Related CN102166303B (en) | 2011-03-27 | 2011-03-27 | Chinese medicinal composition for treating chronic atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166303B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895549B (en) * | 2012-11-13 | 2014-03-12 | 李新欣 | Traditional Chinese medicine for treating chronic atrophic gastritis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1833688A (en) * | 2006-01-09 | 2006-09-20 | 陕西东泰制药有限公司 | Medicine for treating gastro-duodenal ulcer and chronic gastritis and its prepn. |
| CN101244203B (en) * | 2008-02-03 | 2010-07-21 | 李爱英 | Chinese medicine for treating acute and chronic gastritis, enteritis |
-
2011
- 2011-03-27 CN CN2011100859401A patent/CN102166303B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166303A (en) | 2011-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN103908640A (en) | Traditional Chinese medicinal composition for treating liver cirrhosis | |
| CN102406821B (en) | Traditional Chinese medicine for treating simple goiter | |
| CN104001008A (en) | Traditional Chinese medicine composition treating tinnitus cerebri with syndrome of marrow depletion due to kidney deficiency and preparation method thereof | |
| CN103893674A (en) | Traditional Chinese medicinal pill for liver disease treatment and detoxification | |
| CN103316317A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN108653434A (en) | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101530594B (en) | Ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis | |
| CN106214986A (en) | A kind of Chinese medicine decoction treating cardiovascular and cerebrovascular disease | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN105535193A (en) | Traditional Chinese medicine beverage capable of relaxing bowels | |
| CN106074912B (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases | |
| CN104398975A (en) | Traditional Chinese medicinal preparation for treating fibroadenoma of breast and preparation method thereof | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN101985027A (en) | Chinese herbal medicine for treating liver cirrhosis | |
| CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20130327 |